Use of Bisection to Reduce Mitochondrial DNA in the Bovine Oocyte
July 6th, 2022
Here, we present a protocol to significantly reduce the mitochondrial DNA copy numbers in a bovine oocyte (P < 0.0001). This method utilizes centrifugation and bisection to substantially reduce oocyte mitochondria and may allow for an increased chance of development in the reconstructed interspecies somatic cell nuclear transfer embryos.
Overview
This article presents a protocol that significantly reduces mitochondrial DNA copy numbers in bovine oocytes, potentially enhancing the development of reconstructed interspecies somatic cell nuclear transfer embryos. The method employs centrifugation and bisection techniques to achieve over a 90% reduction in mitochondrial DNA.
Key Study Components
Area of Science
- Reproductive Biology
- Cloning Techniques
- Mitochondrial Genetics
Background
- Mitochondrial DNA copy number is crucial for oocyte quality.
- High mitochondrial DNA levels can lead to heteroplasmy in cloned embryos.
- Reducing mitochondrial DNA may improve cloning success rates.
- Interspecies somatic cell nuclear transfer presents unique challenges.
Purpose of Study
- To develop a method for reducing mitochondrial DNA in bovine oocytes.
- To assess the impact of reduced mitochondrial DNA on embryo development.
- To provide a protocol that can be utilized in cloning research.
Methods Used
- Collection of mature oocytes using a pipette.
- Placement of oocytes in HSOF CB solution.
- Centrifugation at 15,000 times G for 12 minutes.
- Evaluation of mitochondrial DNA copy number post-treatment.
Main Results
- Achieved over 90% reduction in mitochondrial DNA copy numbers.
- Demonstrated potential for reducing mitochondrial heteroplasmy.
- Provided a reproducible protocol for future cloning studies.
- Showed significant statistical results (P < 0.0001).
Conclusions
- The protocol effectively reduces mitochondrial DNA in bovine oocytes.
- This reduction may enhance the viability of cloned embryos.
- Further research is needed to explore long-term effects on embryo development.
Frequently Asked Questions
Executive Industry Relevance
Reducing mitochondrial DNA (mtDNA) copy number in bovine oocytes addresses a key challenge in interspecies somatic cell nuclear transfer (iSCNT) by minimizing mitochondrial heteroplasmy, which can compromise embryo development. This protocol enables precise depletion of recipient mtDNA, supporting more predictable nuclear-mitochondrial compatibility in reconstructed embryos. The approach enhances mechanistic de-risking at the earliest stages of cloning and reproductive biotechnology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of mitochondrial-nuclear interactions in engineered embryos.
- Supports functional validation of mtDNA depletion strategies for developmental biology.
- Facilitates mechanistic de-risking of mitochondrial heteroplasmy in cloning workflows.
Screening & Assay Development
- Prepares oocytes with defined mtDNA content for downstream nuclear transfer assays.
- Standardizes biological inputs for reproducible embryo reconstruction experiments.
- Enables quantitative assessment of mtDNA reduction using qPCR-based readouts.
Translational & Preclinical Research
- Aligns with translational goals in species conservation and reproductive cloning.
- Provides continuity from oocyte engineering to embryo viability assessment.
- Supports risk-adjusted advancement of cloning protocols for endangered species rescue.
Pipeline & Workflow Integration
This mtDNA depletion protocol fits at the interface of oocyte preparation and nuclear transfer in the cloning discovery continuum, directly impacting the quality of reconstructed embryos.
- Discovery Biology: Enables hypothesis testing on the impact of mtDNA content on embryo development.
- Screening: Provides standardized, mitochondria-depleted oocytes for reproducible nuclear transfer experiments.
- Analytics: Delivers quantitative mtDNA copy number measurements via qPCR for condition comparison.
- Translational Research: Supports continuity from engineered oocyte to preclinical embryo assessment in conservation pipelines.
- Enterprise Reuse: Establishes a reusable protocol for mtDNA manipulation across cloning and reproductive biology projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in embryo viability by reducing mitochondrial heteroplasmy.
- Operational Value: Standardizes oocyte preparation for scalable and reproducible cloning workflows.
- Strategic Value: Improves go/no-go decision-making for nuclear transfer experiments and resource allocation.
- Portfolio Impact: Enables risk-adjusted prioritization of cloning and conservation projects based on mechanistic clarity.
Implementation Considerations
- Requires expertise in oocyte manipulation and microblade bisection techniques.
- Demands access to centrifugation, qPCR, and precise micromanipulation instrumentation.
- Necessitates cross-team standardization of bisection and sorting procedures for reproducibility.
- May require adaptation for oocytes from different species or developmental stages.
- Success depends on accurate orientation, bisection, and sorting to achieve targeted mtDNA reduction.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:47
Centrifugation of the Oocytes
1:51
Preparation of the Oocyte for Bisection
3:00
Bisection of the Oocytes
4:56
Results: Successful and Unsuccessful qPCR Results and Boxplot from Mitochondria-Reduced and Mitochondria-Dense Ooplasts
5:39
Conclusion
